| First-line immunotherapy-based combinations for metastatic renal cell carcinoma: a systematic review and network meta-analysis F Quhal, K Mori, A Bruchbacher, I Resch, H Mostafaei, B Pradere, ... European Urology Oncology 4 (5), 755-765, 2021 | 124 | 2021 |
| Reliability of serial prostate magnetic resonance imaging to detect prostate cancer progression during active surveillance: a systematic review and meta-analysis P Rajwa, B Pradere, F Quhal, K Mori, E Laukhtina, NA Huebner, ... European urology 80 (5), 549-563, 2021 | 80 | 2021 |
| Guideline of the guidelines: urolithiasis F Quhal, C Seitz Current opinion in urology 31 (2), 125-129, 2021 | 72 | 2021 |
| Apalutamide, enzalutamide, and darolutamide for non-metastatic castration-resistant prostate cancer: a systematic review and network meta-analysis K Mori, H Mostafaei, B Pradere, RS Motlagh, F Quhal, E Laukhtina, ... International journal of clinical oncology 25, 1892-1900, 2020 | 67 | 2020 |
| Androgen receptor signaling inhibitors in addition to docetaxel with androgen deprivation therapy for metastatic hormone-sensitive prostate cancer: a systematic review and meta … T Yanagisawa, P Rajwa, C Thibault, G Gandaglia, K Mori, T Kawada, ... European urology 82 (6), 584-598, 2022 | 58 | 2022 |
| The predictive value of programmed death ligand 1 in patients with metastatic renal cell carcinoma treated with immune-checkpoint inhibitors: a systematic review and meta-analysis K Mori, M Abufaraj, H Mostafaei, F Quhal, H Fajkovic, M Remzi, ... European Urology 79 (6), 783-792, 2021 | 58 | 2021 |
| A systematic review and meta-analysis of variant histology in urothelial carcinoma of the bladder treated with radical cystectomy K Mori, M Abufaraj, H Mostafaei, F Quhal, PI Karakiewicz, A Briganti, ... The Journal of urology 204 (6), 1129-1140, 2020 | 58 | 2020 |
| Systemic therapies for metastatic hormone‐sensitive prostate cancer: network meta‐analysis K Mori, H Mostafaei, R Sari Motlagh, B Pradere, F Quhal, E Laukhtina, ... BJU international 129 (4), 423-433, 2022 | 47 | 2022 |
| The risk of new onset dementia and/or Alzheimer disease among patients with prostate cancer treated with androgen deprivation therapy: a systematic review and meta-analysis R Sari Motlagh, F Quhal, K Mori, N Miura, A Aydh, E Laukhtina, B Pradere, ... The Journal of Urology 205 (1), 60-67, 2021 | 41 | 2021 |
| Diagnostic performance of prostate-specific membrane antigen positron emission tomography–targeted biopsy for detection of clinically significant prostate cancer: a systematic … T Kawada, T Yanagisawa, P Rajwa, RS Motlagh, H Mostafaei, F Quhal, ... European urology oncology 5 (4), 390-400, 2022 | 40 | 2022 |
| En Bloc Resection for Bladder Tumors: An Updated Systematic Review and Meta-Analysis of Its Differential Effect on Safety, Recurrence and Histopathology T Yanagisawa, K Mori, RS Motlagh, T Kawada, H Mostafaei, F Quhal, ... The Journal of Urology 207 (4), 754-768, 2022 | 40 | 2022 |
| Penile rehabilitation strategy after nerve sparing radical prostatectomy: a systematic review and network meta-analysis of randomized trials R Sari Motlagh, M Abufaraj, L Yang, K Mori, B Pradere, E Laukhtina, ... The Journal of urology 205 (4), 1018-1030, 2021 | 40 | 2021 |
| Sequential therapy of abiraterone and enzalutamide in castration-resistant prostate cancer: a systematic review and meta-analysis K Mori, N Miura, H Mostafaei, F Quhal, R Sari Motlagh, B Pradere, ... Prostate Cancer and Prostatic Diseases 23 (4), 539-548, 2020 | 34 | 2020 |
| Low compliance to guidelines in nonmuscle-invasive bladder carcinoma: a systematic review K Mori, N Miura, M Babjuk, PI Karakiewicz, H Mostafaei, E Laukhtina, ... Urologic Oncology: Seminars and Original Investigations 38 (10), 774-782, 2020 | 34 | 2020 |
| Efficacy of neoadjuvant and adjuvant chemotherapy for localized and locally advanced upper tract urothelial carcinoma: a systematic review and meta-analysis F Quhal, K Mori, R Sari Motlagh, E Laukhtina, B Pradere, M Rouprêt, ... International journal of clinical oncology 25, 1037-1054, 2020 | 34 | 2020 |
| Discordance between clinical and pathological staging and grading in upper tract urothelial carcinoma K Mori, S Katayama, E Laukhtina, VM Schuettfort, B Pradere, F Quhal, ... Clinical Genitourinary Cancer 20 (1), 95. e1-95. e6, 2022 | 30 | 2022 |
| The prognostic impact of intraductal carcinoma of the prostate: a systematic review and meta-analysis N Miura, K Mori, H Mostafaei, F Quhal, RS Motlagh, B Pradere, ... The Journal of urology 204 (5), 909-917, 2020 | 28 | 2020 |
| Differential effect of sex on outcomes after radical surgery for upper tract and bladder urothelial carcinoma: a systematic review and meta-analysis K Mori, H Mostafaei, DV Enikeev, I Lysenko, F Quhal, S Kimura, ... The Journal of urology 204 (1), 58-62, 2020 | 28 | 2020 |
| Pretreatment clinical and hematologic prognostic factors of metastatic urothelial carcinoma treated with pembrolizumab: a systematic review and meta-analysis T Yanagisawa, K Mori, S Katayama, H Mostafaei, F Quhal, E Laukhtina, ... International Journal of Clinical Oncology, 1-13, 2022 | 26 | 2022 |
| Incidence and outcome of salvage cystectomy after bladder sparing therapy for muscle invasive bladder cancer: a systematic review and meta-analysis VM Schuettfort, B Pradere, F Quhal, H Mostafaei, E Laukhtina, K Mori, ... World Journal of Urology 39, 1757-1768, 2021 | 26 | 2021 |
Shahrokh F. Shariat, M.D.Department of Urology, Comprehensive Cancer Center, Medical University of Vienna and General在 meduniwien.ac.at 的电子邮件经过验证
